{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:48:08Z","timestamp":1791805688600,"version":"4.3.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Australas Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Schizophrenia and schizoaffective disorder are complex, lifelong disorders. This study evaluates antipsychotic medication use and the management of inpatients diagnosed with these conditions to better inform health service providers about patient characteristics and prescribing patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective chart review of electronic medical records (EMRs) of a randomly chosen subset of inpatients diagnosed with schizophrenia or schizoaffective disorder at Lyell McEwin Hospital (LMH) and Modbury Hospital in Adelaide, South Australia, from 01 January\u201331 December 2022, inclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 101 patients with eligible inpatient admissions. Of 123 admissions during the 12-month observation period, 22 were readmissions. Worsening of positive symptoms (91.1%) was the most frequently reported primary reason for admission. During the first inpatient stay, 97.0% were prescribed maintenance antipsychotics and 92.1% at least one oral antipsychotic (OA). Polypharmacy occurred in 29.7% and antipsychotic switching in 22.8%. Oral second-generation antipsychotics (SGAs) had the highest discontinuation rate (49.5%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Several hospital patient management practices at LMH and Modbury Hospital aligned with Australian guidelines and published evidence. However, it is important to highlight any notable deviations, such as a lack of metabolic screening prior to and during treatment, as it may help other providers improve their standard of care for patients with schizophrenia or schizoaffective disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10398562261431614","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:12:44Z","timestamp":1773893564000},"page":"473-482","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating antipsychotic prescribing trends and patient outcomes in schizophrenia and schizoaffective disorder: Insights from a year-long observational study across two tertiary mental health treatment centres in South Australia"],"prefix":"10.1177","volume":"34","author":[{"given":"Dennis","family":"Liu","sequence":"first","affiliation":[{"name":"Northern Community Mental Health Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nowak","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit Lyell McEwin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deb","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit Lyell McEwin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-6345","authenticated-orcid":false,"given":"Sam","family":"Colman","sequence":"additional","affiliation":[{"name":"Fortrea Australia Pty Ltd, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Oliver","family":"Schubert","sequence":"additional","affiliation":[{"name":"Northern Community Mental Health Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2967-3415","authenticated-orcid":false,"given":"Mihalina","family":"Georgallis","sequence":"additional","affiliation":[{"name":"Fortrea Market Access &amp; HEOR Consulting, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Noke","sequence":"additional","affiliation":[{"name":"Former Employee of Otsuka Australia Pharmaceutical Pty Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-7146","authenticated-orcid":false,"given":"Simon","family":"Graham","sequence":"additional","affiliation":[{"name":"Lundbeck Australia Pty Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"e_1_3_9_2_2","unstructured":"Monash University. Schizophrenia\/psychosis. Available at: https:\/\/www.monash.edu\/medicine\/her-centre\/education\/resources\/schizophreniapsychosis (Accessed October 2025)."},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.67"},{"key":"e_1_3_9_4_2","volume-title":"Schizoaffective disorder. StatPearls. Treasure Island (FL): Statpearls publishing copyright \u00a9 2025","author":"Wy TJP","year":"2025","unstructured":"Wy TJP, Saadabadi A. Schizoaffective disorder. StatPearls. Treasure Island (FL): Statpearls publishing copyright \u00a9 2025. StatPearls Publishing LLC, 2025."},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2018.72"},{"key":"e_1_3_9_6_2","unstructured":"AIHW. Admitted patient mental health related care. Available at: https:\/\/www.aihw.gov.au\/getmedia\/8ba8bedc-f902-478e-9d15-45c2e46a4623\/admitted-mental-health-related-hospitalisations-2020-21.pdf (Accessed October 2025)."},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0004867416641195"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.18306"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-8-32"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903488670"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.12.009"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2012.683523"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(24)00314-6"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.07.006"},{"key":"e_1_3_9_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.2051-5545.2009.tb00199.x"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00126.x"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30416-X"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412443900"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2018.12.004"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.08.023"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/10673229909017206"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-005-0082-8"},{"key":"e_1_3_9_23_2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S171002"},{"key":"e_1_3_9_24_2","doi-asserted-by":"publisher","DOI":"10.4102\/SAJPSYCHIATRY.v30i0.2237"},{"key":"e_1_3_9_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/10398562211054656"},{"key":"e_1_3_9_26_2","first-page":"603","article-title":"Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studies","volume":"44","author":"Kishimoto T","year":"2018","unstructured":"Kishimoto T, Hagi K, Nitta M, et al. Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studies. SBO 2018; 44: 603\u2013619. https:\/\/doi.org\/10.1093\/schbul\/sbx090","journal-title":"SBO"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04912gre"},{"key":"e_1_3_9_28_2","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2023.06.147"},{"key":"e_1_3_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.102022"},{"key":"e_1_3_9_30_2","first-page":"sgac013","article-title":"Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary: an update","volume":"3","author":"Tak\u00e1cs P","year":"2022","unstructured":"Tak\u00e1cs P, Kunovszki P, Timtschenko V, et al. Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary: an update. SBO 2022; 3: sgac013. https:\/\/doi.org\/10.1093\/schizbullopen\/sgac013","journal-title":"SBO"},{"key":"e_1_3_9_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1379412"}],"container-title":["Australasian Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10398562261431614","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10398562261431614","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10398562261431614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:16:21Z","timestamp":1791803781000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10398562261431614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1177\/10398562261431614"],"URL":"https:\/\/doi.org\/10.1177\/10398562261431614","relation":{},"ISSN":["1039-8562","1440-1665"],"issn-type":[{"value":"1039-8562","type":"print"},{"value":"1440-1665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}